Medistim ASA (LON:0OCD)
229.00
+9.00 (4.09%)
At close: Jul 3, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Third Party Products | 89.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Products Growth | 22.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -6.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) | 61.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Growth | -5.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) | 39.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Growth | 13.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Systems | 55.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Systems Growth | 1.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow and Imaging Systems | 69.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow and Imaging Systems Growth | 19.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Probes | 231.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Probes Growth | 20.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Imaging Probes | 16.08M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Imaging Probes Growth | 18.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Coronary Surgery | 379.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Coronary Surgery Growth | 11.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vascular Surgery | 93.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vascular Surgery Growth | 23.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Products | 89.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Products Growth | 22.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -6.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Third Party Products | 89.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Products Growth | 22.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 466.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 13.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Products | 89.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Third Party Products Growth | 22.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas | 237.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Growth | 23.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC | 65.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Growth | 0.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA | 170.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Growth | 7.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 466.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 13.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USA | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest Of The World | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest Of The World Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold | 23.54K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold Growth | -7.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold | 7.48K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold Growth | -1.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Flow Systems (PPP/Lease) Units Sold | 4.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold | 5.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Systems Units Sold | 116.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Systems Units Sold Growth | 25.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow and Imaging Systems Units Sold | 66.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow and Imaging Systems Units Sold Growth | 73.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Probes Units Sold | 9.63K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Flow Probes Units Sold Growth | 18.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Imaging Probes Units Sold | 132.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capital Sales - Imaging Probes Units Sold Growth | 50.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|